hTARDBP-A315T
Nomenclature
C57BL/6JSmo-Tardbptm1(hTARDBP-A315T)Smoc
Cat. NO.
NM-HU-241225
Strain State
Repository Live
Gene Summary
Gene Symbol
Tardbp
Model Description
Validation Data
Fig.1 Detection of TARDBP expression in frontal lobe by RT-PCR. Mouse Tardbp mRNA (174 bp) was detectable only in wild-type C57BL/6 mice. Human TARDBP mRNA (449 bp) was detectable only in homozygous hTARDBP-A315T knockin mice but not in wild-type mice. Frontal lobe RNA was extracted from 7-year-old male wild-type C57BL/6 (WT)(n=3) and female homozygous hTARDBP-A315T knockin mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HO, homozygous; WT, wild type.
Fig.3 Detection of hTARDBP expression in hTARDBP-A315T mice by WB. Human TARDBP was robustly expressed in the brain and spinal cord of homozygous hTARDBP-A315T mice. Lysates of brain and spinal cord tissues were collected from 7-week-old female wild-type C57BL/6 mice and 7-week-old female homozygous hTARDBP-A315T mice, then analyzed by western blot with anti-hTARDBP antibody .
Abbr. HO, homozygous; WT, wild type.
Fig.4 Detection of hTARDBP expression in hTARDBP-A315T mice by WB. Significant overexpression of TARDBP was observed in the brain and spinal cord of homozygous hTARDBP-A315T mice relative to WT C57BL/6 mice, as measured by an antibody cross-reactive with both human and mouse TARDBP. The brain and spinal cord tissue lysates were collected from 7-week-old female wild-type C57BL/6 mice and 7-week-old female homozygous hTARDBP-A315T mice, and then analyzed by western blot.
Abbr. HO, homozygous; WT, wild type; PC, positive control, Hela cells.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
